Navigation Links
GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSK's Candidate Pre-pandemic Flu Vaccine to Start.
Date:8/19/2007

ng governments and public health officials around the world effectively respond to the global threat of a flu pandemic and we are pleased to be working with the US government in its preparedness efforts."

Initiation of H5N1 clinical trials

Today also marked the start of the first pre-pandemic vaccine trials involving GSK's proprietary adjuvanted H5N1 vaccine in North America. The vaccine used in these trials will be produced at the company's North American manufacturing facility in Quebec, Canada. These U.S. studies are supported by a contract [HHS100200700029C] from BARDA/ASPR/HHS awarded in January 2007 for the advanced development of antigen-sparing pandemic influenza vaccines towards U.S.-licensure with a commitment to U.S. production of 150 million doses of pandemic vaccine within six months of a pandemic onset.

The trials highlight the company's continuing commitment to its global pre-pandemic influenza vaccine development program. Data from earlier European studies, using a pre-pandemic vaccine produced at GSK's Dresden, Germany facility, showed that the influenza candidate vaccine may be able to induce immune responses that might protect against different strains of H5N1.

GSK's first North American pre-pandemic vaccine trial will be a Phase I/II study that evaluates its H5N1 antigen alone and in combination with one of its proprietary Adjuvant Systems, in 675 subjects. This Phase I/II study is expected to lead into a larger, multi-center, Phase III trial - one of the largest in North America - which is expected to enroll approximately 4,400 subjects later in 2007.

Ripley Ballou, Vice President of Clinical Development for Flu at GlaxoSmithKline said: "The goal of our North American clinical development program is to establish GSK's second manufacturing facility as a source for H5N1 vaccine, further strengthening our efforts to support governments' pandemic preparedness strategies. The initiation of these trials underscores the im
'/>"/>

SOURCE GlaxoSmithKline

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. GlaxoSmithKline and Genmab Present Positive Phase II Results With ofatumumab in Patients With Rheumatoid Arthritis (RA)
2. GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets Phase II Study Endpoints of Immunogenicity and Safety Compared to Licensed Vaccines
3. New Data on Genmab and GlaxoSmithKlines Ofatumumab: Phase II Study in Rheumatoid Arthritis to be Presented at EULAR
4. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
5. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
6. DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan PDT to Treat Esophage al Dysplasia
7. Gloucester Pharmaceuticals Receives Fast Track Designation for Romidepsin in Peripheral T-Cell Lymphoma
8. Researchers Discover Gene For Rare Skin Disorder
9. Remarks by President Bush on Stem Cell Veto and Executive Order
10. IMPAX Presents at Movement Disorder Societys 11th International Congress of Parkinsons Disease and Movement Disorders
11. International Movement Disorder Specialists Receive New Information About the Use of Once-Daily Azilect in the Treatment of Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... CHENGDU, China , July 30, 2015 ... "Company"), a pharmaceutical company that specializes in the patented ... active pharmaceutical ingredients (API), provided updates regarding the notice ... MKT LLC (the "Exchange") indicating that the Company was ... set forth in Sections 134 and 1101 of the ...
(Date:7/30/2015)... 2015  Growth of the U.S. nonprescription market is ... prescription users to the OTC market. Due to an ... Rx-to-OTC switch activity over the next five years with ... new brands entering the market into existing categories. ... years (even those with low to moderate likelihood), the ...
(Date:7/30/2015)... July 30, 2015  Medimetriks Pharmaceuticals, Inc. announced ... Phase III clinical study for Ozenoxacin, a novel ... owns the exclusive U.S. rights to Ozenoxacin 1% ... at 44 centers with an emphasis on U.S. ... 2 months and older with a clinical diagnosis ...
Breaking Medicine Technology:TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3
(Date:7/31/2015)... York (PRWEB) , ... July ... ... attorney Jason T. Brown’s live lecture on pharmaceutical negligence is now available ... 2015 was well received with a 94% approval rating from the nationwide ...
(Date:7/31/2015)... ... ... As part of their company mission, Dallas pet sitting company Park ... to the longevity of their business. It is for that reason they are ... (NAPPS) annual Presents 4 Pets supply drive. Presents 4 Pets is a ...
(Date:7/31/2015)... Schenectady, New York (PRWEB) , ... July 31, 2015 , ... ... first half of 2015. , Total sales were up 16 percent year-over-year for the ... President and CEO Antonio Civitella said he expected Transfinder to beat last year’s record-revenue ...
(Date:7/31/2015)... ... July 31, 2015 , ... “Engage: ... of the industry’s premier thought leadership symposiums, hosted by Massachusetts-based Harmony Healthcare ... The event attracts over 250 “C”-level executives, administrators, directors of nursing, rehabilitation managers ...
(Date:7/31/2015)... ... 31, 2015 , ... Mullin/Ashley Associates , a Mid-Atlantic ... Aster Awards national competition for a marketing communications campaign created for Atlantic ... in Coastal Maryland and Southern Delaware. , A Bronze Award was won for ...
Breaking Medicine News(10 mins):Health News:Re-Broadcast of Nationally Renowned Trial Attorney Jason T. Brown's Lecture on Pharmaceutical Negligence Now Available 2Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 2Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 3Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 4Health News:Transfinder Closes First Half of 2015 with Record Revenue 2Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 2Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 3Health News:Mullin/Ashley Associates Wins in the 2015 Aster Awards National Competition for Excellence in Medical Marketing 2
... It ... as it makes its final push to overhaul America,s health care system. However, according ... on many of the President,s reform proposals, and even reject a number of Obama,s favored ... Washington, D.C. ...
... , , , CINCINNATI ... today that Mr. David Vucurevich R.Ph. has joined the company ... Mr. Vucurevich will be responsible for guiding the corporation,s long-term ... Chairman and Chief Executive Officer of Prasco. , ...
... , , , ... , WASHINGTON, Sept. 22 The health care network operated by the ... this year for workers over 50 by the American Association of Retired Persons (AARP). ... primary mission," said Secretary of Veterans Affairs Eric K. Shinseki. "VA is proud ...
... , , SAN DIEGO, Sept. 22 ... company, held its Annual Meeting of the Shareholders for the fiscal year ... Mar Hilton in Del Mar, California. The business matters considered and acted ... of directors of the Company at six and election of six directors, ...
... , , Generous ... , , WASHINGTON , Sept. 22 ... program to help both schools and businesses in 16 U.S. cities ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090108/RedCrossLOGO ) , , Schools and ...
... Physical therapist-directed exercise counseling combined with fitness center-based ... capacity in people with type 2 diabetes, with ... to a randomized clinical trial published in the ... scientific journal of the American Physical Therapy Association ...
Cached Medicine News:Health News:Union Members Reject Key Tenets of "Obamacare" - According to Recent Zogby/O'Leary Poll 2Health News:Union Members Reject Key Tenets of "Obamacare" - According to Recent Zogby/O'Leary Poll 3Health News:Union Members Reject Key Tenets of "Obamacare" - According to Recent Zogby/O'Leary Poll 4Health News:Union Members Reject Key Tenets of "Obamacare" - According to Recent Zogby/O'Leary Poll 5Health News:Union Members Reject Key Tenets of "Obamacare" - According to Recent Zogby/O'Leary Poll 6Health News:Union Members Reject Key Tenets of "Obamacare" - According to Recent Zogby/O'Leary Poll 7Health News:Prasco Names David Vucurevich as Senior Vice President of Corporate Development 2Health News:VA's Health System Top Employer for AARP 2Health News:SpectraScience Announces Results of Annual Shareholder Meeting 2Health News:SpectraScience Announces Results of Annual Shareholder Meeting 3Health News:American Red Cross Launches Ready Rating Program to Prepare Businesses and Schools for Emergencies in 16 U.S. Cities From Coast to Coast 2Health News:American Red Cross Launches Ready Rating Program to Prepare Businesses and Schools for Emergencies in 16 U.S. Cities From Coast to Coast 3Health News:American Red Cross Launches Ready Rating Program to Prepare Businesses and Schools for Emergencies in 16 U.S. Cities From Coast to Coast 4Health News:People with type 2 diabetes improved muscular strength 2
... anti-reflux valve is enclosed in ... prevents the valve from being ... sitting or reclining positions. The ... interference free ensuring uninterrupted flow ...
Intermittent catheter - SpeediCath™ is pre-hydrated and ready to use right out of the package. Just open, cath and get on with your life....
The Medtronic® Resting Heart™ System offers a new approach to reducing cardiac surgery morbidity....
This adapter features a female luer on the single leg. A rigid "Y" has two legs with white clamps and terminate with male luers....
Medicine Products: